Blister pack with dollars instead of pills In the midst of a pandemic, the drug industry islikely at least in the short term to see a boost to its bottomlines. (Photo: Shutterstock)

Just as other products have seen sales and profits go throughthe roof as people stocked up on goods in response to lockdowns,pharmaceutical company Eli Lilly has not only beat quarterlyestimates but also boosted its profit forecast for 2020 ascustomers have stocked up on such drugs as its diabetes drugTrulicity and psoriasis drug Taltz.

According to a Reuters report, the company did warn that thephenomenon would likely reverse over the course of the year and itcould still be hit with a negative impact to drug prices given thetoll coronavirus is taking on the economy.

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

  • Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Marlene Satter

Marlene Y. Satter has worked in and written about the financial industry for decades.